Status:
COMPLETED
A Study Comparing the Laryngeal Mask Airway Supreme With the Laryngeal Mask Airway Protector In the Ambulatory Surgery Unit
Lead Sponsor:
University Hospital, Ghent
Conditions:
Airway Complication of Anesthesia
Eligibility:
All Genders
19-71 years
Phase:
NA
Brief Summary
The Laryngeal Mask Airway is a supraglottic airway device that has been used in anesthesia for decades. Now the third generation (LMA Supreme) is commonly used. Recently the LMA Protector is manufactu...
Detailed Description
1. Outpatients planned for elective minor surgery, routinely done with LMA, will be asked to participate in the study. 2. The patient is preoxygenated for 3 min. Anaesthesia is induced with 0.15 mcg/k...
Eligibility Criteria
Inclusion
- Patients who are planned for elective minor surgery in the ambulatory surgery unit, who are ASA I or II or III, aged 19-71 years, whose operation is routinely done with a Laryngeal Mask Airway in the supine position.
Exclusion
- Patients are excluded if they are \<19 or \>71 years, have an anticipated difficult airway, a body mass index \> 35kg.m-2 or are at risk of aspiration.
Key Trial Info
Start Date :
July 26 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 21 2018
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03462550
Start Date
July 26 2017
End Date
March 21 2018
Last Update
January 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ghent
Ghent, Belgium